Cargando…
Eosinophilic Fasciitis with Concurrent Necrobiotic Granulomatous Dermatitis Related to Checkpoint Inhibition Therapy
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapeutics. However, loss of physiologic tolerance in few cases has triggered rare and novel immune-related adverse events (irAEs). Eosinophilic fasciitis, an infrequently reported diffuse scleroderma-like entity, has been associated w...
Autores principales: | Haroon, Adeeb, Tadros, Joseph, Smith, Emily H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Innovative Healthcare Institute
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153248/ https://www.ncbi.nlm.nih.gov/pubmed/35664087 http://dx.doi.org/10.36401/JIPO-21-19 |
Ejemplares similares
-
Eosinophilic Fasciitis following Checkpoint Inhibitor Therapy with Pembrolizumab
por: Zampeli, Evangelia, et al.
Publicado: (2021) -
Necrobiotic Xanthogranuloma
por: Girisha, Banavasi S, et al.
Publicado: (2012) -
Drug-Associated Eosinophilic Fasciitis: A Case of Eosinophilic Fasciitis Secondary to Cemiplimab Therapy
por: Boppana, Sri Harsha, et al.
Publicado: (2021) -
Eosinophilic fasciitis
por: Lamback, Elisa Baranski, et al.
Publicado: (2016) -
An Exuberant Case of Necrobiotic Xanthogranuloma
por: Lopes, Sofia, et al.
Publicado: (2019)